In 2012, preliminary data from patients with advanced solid tumors (melanoma, non-small cell lung cancer, and colorectal cancer; n = 236) treated with nivolumab monotherapy demonstrated a relationship between PD-L1 expression in tumor cells and ORR (36%) [61]. The gene discussed is CD274; the disease is neoplasm.